Emeriane Avocats counsel to Brink Therapeutics, a French TechBio specializing in gene editing and gene therapies, in connection with its €3.5m seed financing round

The goal of this first round of financing led by Kurma Partners and Breega is to deploy Brink Therapeutics’ revolutionary gene-editing technology and become a world leader in the discovery and development of therapeutic recombinases.

Congratulations to the founders of Brink Therapeutics (Jonathan Naccache, Harry Kemble and Andrew Griffiths) and all persons involved in the success of this transaction, including our counterparts at Goodwin France (Anne-Charlotte Rivière and Charlotte Muller)!

FOCUS - April 14, 2021

Emeriane Avocats, counsel to Getlink in the acquisition of Associated Shipping Agencies (A.S.A) and Boulogne International Maritime Services (BIMS)

DEAL - 11 APRIL 2023

Emeriane Avocats advised IFESO on the sale of a majority stake to DCI

Emeriane Avocats, counsel to the founders of Hellow, a specialist in operated offices, in connection with its acquisition by Comeandwork

STUDY - 23 April 2025

Emeriane Avocats counsel to Brink Therapeutics, a French TechBio specializing in gene editing and gene therapies, in connection with its €3.5m seed financing round

10 legal steps of a fundraising campaign

We are delighted to announce that Juliette Robin has joined our team as an associate!

Focus on bonds convertible into shares

The main legal steps of a contribution in kind

Main points to keep in mind when drafting Articles of Association of a French société par actions simplifiée (SAS)

BSPCE (Founders’ share subscription warrants)

Emeriane Avocats, counsel to Getlink in the acquisition of Associated Shipping Agencies (A.S.A) and Boulogne International Maritime Services (BIMS)

Emeriane Avocats advised IFESO on the sale of a majority stake to DCI

Emeriane Avocats, counsel to the founders of Hellow, a specialist in operated offices, in connection with its acquisition by Comeandwork

Partial Transfer of Assets – JurisClasseur Corporate Law Study (LexisNexis)

Focus on the vigilance plan

Creation of Emeriane Avocats, Business Partner of New Growth

Focus on the priorities of the French Market Authority (AMF) for 2021

CSR : legal framework applicable to listed companies

Focus on the “raison d’être” (corporate purpose) of companies

Regulations on Products and Packaging – What Are the Key Legislative and Regulatory Developments in France and Europe?

Focus on the audit of the non-financial performance statement (NFPS)

VSEs and SMEs: 10 reasons for implementing a CSR policy

MAD30 – Top Legal Voices Maddyness x Lamy Liaisons

Focus on the non-financial performance statement (NFPS)

Training – Regulated Information and Market Abuse Prevention